Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Algernon Pharmaceuticals Inc.
C.AGN
Alternate Symbol(s):
AGNPF
Consumer Cyclical
Healthcare
Advertising Agencies
Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N...
-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:AGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Dec 30, 2021 9:44am
Trading December 29
Yesterday's trading seems to support my statements as to where the price problem lies. While the general atmosphere is anticipation of positive news - absolutely nothing happened to to chamge
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Comment by
C10H12N2
on Dec 29, 2021 7:23pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Question for Whalewatcher
What I think is you are a clown and should direct your posts to someone else. What I think beyond your clownship is irrelevant in these back and forth threads with you. Hence, I am blocking your
...more
Debt-Free and Thriving: Mining Company Reports 35% Revenue Growth in Q3 2024
posted Nov 12, 2024 9:00am by
Mandalay Resources Corp.
-
|
"Revenue growth and free cash flow generation reflect our cost controls and prudent capital management while benefitting from high metal prices. As of the end of Q3 our cash balance was a healthy $54.7 million – more than doubling since December 2023 – and we have fully repaid the $20 million outstanding balance on our revolving credit facility, strengthening our liquidity and financial flexibility ...read more
(2)
•••
Whalewatcher1
X
View Profile
View Bullboard History
Comment by
Whalewatcher1
on Dec 29, 2021 7:14pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Question for Whalewatcher
C10H12N2, what's with calling me clown? I'm just pointing out recent case studies of what happens when CSE or TSXV biotechs uplist to Nasdaq and how stock prices plummeted. This is contrary to
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Comment by
C10H12N2
on Dec 29, 2021 6:36pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Question for Whalewatcher
What I think is Whalewatcher1 is an ALL OUT CLOWN. Neither XORTX or Diamedica Therapeutics have any drugs in their pipeline that matches up with Algernon Pharmaceuticals. Try at least matching apples
...more
(2)
•••
Whalewatcher1
X
View Profile
View Bullboard History
Comment by
Whalewatcher1
on Dec 29, 2021 4:45pm
RE:RE:RE:RE:RE:RE:RE:RE:Question for Whalewatcher
You should check out the streetwise report on algernon today. Keep in mind that algernon pays for this report. Chris provides examples of Nasdaq up listing in xortx and Diamedica, neither worked
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Comment by
C10H12N2
on Dec 28, 2021 8:48pm
RE:RE:RE:RE:RE:RE:RE:Question for Whalewatcher
I say exactly what I think. Always have and always will. You apparently know Jack shii about me. Your personal attack is unwarranted. That's what I get for trying to help you better understand the
...more
(2)
•••
Whalewatcher1
X
View Profile
View Bullboard History
Comment by
Whalewatcher1
on Dec 28, 2021 7:36pm
RE:RE:RE:RE:RE:RE:Question for Whalewatcher
Just trying to get to the truth, would you really trust talking with algernon management on this topic? Based on your earlier comments i think the answer is an obvious NO. I just think you are
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Comment by
C10H12N2
on Dec 28, 2021 7:02pm
RE:RE:RE:RE:RE:Question for Whalewatcher
ROTFLMAO. You don’t believe they have an understanding of the uplist. Meanwhile, you need to be pointed to the correct page of the Nasdaq Guidelines. Now you're an expert based on Andre Uddin
...more
(2)
•••
Whalewatcher1
X
View Profile
View Bullboard History
Comment by
Whalewatcher1
on Dec 28, 2021 5:40pm
RE:RE:RE:RE:Question for Whalewatcher
I could be wrong. But if you go look up for youself how stocks trade post Nasdaq listing. CSE/TSXV listed stocks never double or so just because they list on Nasdaq . . . We both agree that they need
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Dec 28, 2021 5:21pm
Here's one way you got royally screwed by Moreau and Malhi.
Algernon management dumped the FAIMS device at Algernon which was the exact same technology Algernon (formerly Breathtec Biomedical) had been working on in 50/50 partnership with Cannabix
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Comment by
C10H12N2
on Dec 28, 2021 4:52pm
RE:RE:RE:Question for Whalewatcher
We hear you. i simply believe you are flat out wrong. you keeo talking about look at other companies. I don't have to. I'm looking at and comprehending the NASDAQ Guidelines. The same
...more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Comment by
nodaytrader
on Dec 28, 2021 4:39pm
RE:RE:Question for Whalewatcher
Thank you for clarifying the NASDAQ requirements which had been confusing me.
(2)
•••
Whalewatcher1
X
View Profile
View Bullboard History
Comment by
Whalewatcher1
on Dec 28, 2021 4:29pm
RE:RE:Question for Whalewatcher
C10H12N2, my point is simply that the company is currently publicly traded on CSE and OTC. When uplist to Nasdaq, you don't set a new price irrespective of past trading. Share price is based on
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Comment by
C10H12N2
on Dec 28, 2021 4:04pm
RE:Question for Whalewatcher
What you just said needs to be framed here. Thanks for that EZ to follow along example.
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Dec 28, 2021 3:36pm
Question for Whalewatcher
If I read it right, you are arguing that NASDAQ bases its eligibility criteria on data from CSE. My question is "why would they do that?" NASDAQ's trading volume is about US$200 billion
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Meet the Top 5 Best Online Brokerages in Canada
Gold, growth and sustainability in focus for this resource company
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Star Diamond Corporation Announces Third Quarter 2024 Results
Explained: The Psychology of Options Trading with Practical Tips
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023